EMD Millipore Expands Product Portfolio With Merck KGaA Acquisition of Biotest AG’s Microbiology Business

Published: Mar 22, 2011

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore, the Life Science division of Merck KGaA of Germany, today announced plans to expand its industrial microbiological testing portfolio. This follows Merck KGaA‘s announcement it has entered into a definitive agreement to acquire the microbiology business of Germany-based Biotest AG. The acquisition will strengthen EMD Millipore’s Biomonitoring business, further enhancing its strong position in the fast growing industrial microbiology testing market.

Back to news